Deans' stroke musings: Erectile dysfunction linked with increased risk of CV events

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, January 14, 2013

Erectile dysfunction linked with increased risk of CV events

OK, ok, going after the catchy headline. They do make a weak case for ED drugs helping prevent CV events.
http://www.theheart.org/article/1494733.do?utm_medium=email&utm_source=20130114_heartwire&utm_campaign=newsletter
"Improvement of ED by lifestyle interventions per se might be beneficial in terms of prognosis, and our results highlight the role of ED as a potential low-cost biomarker that would call for more aggressive cardiovascular-risk-factor modification," write the authors. "Of special interest is the effect of pharmacological treatment of ED, because it seems that this may also have a beneficial impact on risk."